Ketamine, a hallucinogen and dissociative anesthetic, has been approved to treat treatment-resistant depression. This webinar explores how ketamine treats depression, its efficacy, and its potential side effects. Join us for an informative session with psychopharmacologist Dr. Kristin Nagy as she describes what a ketamine treatment consists of, the safety of this type of treatment, and the results of clinical studies.
Review pathophysiology and symptoms of depression
Outline current depression treatment practices
Summarize a brief history of ketamine
Describe psychopharmacology of ketamine
Discuss possible issues with prolonged use of ketamine
Tue, Jun 15, 2021 · 1:00 PM
Eastern Time (US & Canada)
Dr. Nagy graduated with a PharmD degree from the University at Buffalo in 2006. Kristen has worked for Atrium Health for 13 years, spending the last 7 years specializing in psychiatry at Behavioral Health-Charlotte as the Clinical Pharmacy...